Neuronetics posted preliminary, unaudited fourth-quarter 2025 revenue of $41.8 million and full-year revenue of $149.2 million, with positive operating...

Exousia Pro has signed a third letter of intent to acquire an established telehealth organization, expanding a roll-up that...

Sanofi has completed its acquisition of Dynavax Technologies, adding the marketed adult hepatitis B vaccine Heplisav-B and a Phase...

Day One Biopharmaceuticals will host its fourth-quarter and full-year 2025 results call on February 24, 2026, at 4:30 p.m....

Polaryx Therapeutics has unveiled late-breaking preclinical data for PLX-200, an oral formulation of gemfibrozil, in a Krabbe disease mouse...

Polyrizon, a preclinical-stage biotech developing intranasal hydrogel “biological mask” technologies, has signed a non-binding memorandum of understanding to acquire...

ProQR Therapeutics will rotate co-founder Dinko Valerio and director Alison Lawton off its board at the company’s 2026 annual...

Torii Pharmaceutical, a Shionogi subsidiary, has launched Ycanth in Japan for molluscum contagiosum following Japanese approval in September 2025....

BioSyent is acquiring Oral Science, a Canadian dental-focused distributor, for $25.5 million in cash and stock, with additional contingent...

Memo Therapeutics has signed a strategic collaboration and exclusive option-to-license agreement with CSL to advance recombinant polyclonal IgG products...